Skip to main content

Co-Diagnostics, Inc.

For the period ended Oct 26, 2026. Filed Oct 26, 2026.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Oct 26, 2026 · Filed Oct 26, 2026

Use the contents to explore the available documents and sections.

CODX$0.26-3.9%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Performance Objectives

The Plan provides that performance objectives may be established by the Compensation Committee in connection with any award granted under the Plan. Performance objectives may relate to the performance of the Company or one or more of our subsidiaries, divisions, departments, units, functions, partnerships, joint ventures or minority investments, product lines or products, or the performance of an individual participant, and performance objectives may be made relative to the performance of a group of companies or a special index of companies.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.